Asia-Pacific Women's Health Diagnostics Market
Asia-Pacific Women's Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others), and by End-Users (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period, (2026-2035)
Industry Overview
Asia-Pacific women’s health diagnostics market was valued at $6,100.5 million in 2025 and is projected to reach $13,649.6 million by 2035, growing at a CAGR of 8.4% during the forecast period (2026–2035). The Asia-Pacific women’s health diagnostics market is advancing rapidly as healthcare systems across the region strengthen their focus on early disease detection, maternal health, and preventive screening programs. Growth is being reinforced by rising awareness of women-specific health conditions, expanding access to diagnostic services in emerging economies, and increasing government-led initiatives targeting breast and cervical cancer screening. The adoption of advanced diagnostic technologies, including molecular diagnostics, ultrasound imaging, and point-of-care testing, is accelerating as providers seek cost-effective and scalable solutions. Demand is further supported by a large and aging female population, rising incidence of reproductive and infectious diseases, and improving healthcare infrastructure. As regional healthcare authorities emphasize timely diagnosis and equitable access to care, women’s health diagnostics solutions are becoming critical to improving clinical outcomes and reducing long-term disease burden across Asia-Pacific.
Market Dynamics
Rising Government-Led Screening and Maternal Health Initiatives
Governments across Asia-Pacific are actively expanding national screening programs for breast and cervical cancer, alongside initiatives focused on maternal and reproductive health. Public healthcare investments and partnerships with private diagnostic providers are improving access to early diagnostic services, particularly in emerging economies. These initiatives are increasing test volumes and accelerating adoption of cost-effective diagnostic technologies.
Expanding Healthcare Infrastructure and Technology Adoption
Rapid development of hospitals, diagnostic centers, and laboratory networks is supporting wider deployment of women’s health diagnostics across the region. Advances in molecular diagnostics, ultrasound imaging, and point-of-care testing are gaining traction due to their scalability and suitability for resource-variable settings. As healthcare systems modernize, demand for efficient and accurate diagnostic solutions continues to rise.
Market Segmentation
- Based on the application, the market is segmented into breast cancer testing, cervical cancer testing, pregnancy & fertility testing, ovarian cancer testing, infectious disease testing, ultrasound tests, sexually transmitted disease testing, and others.
- Based on the end-user, the market is segmented into diagnostic and imaging centers, hospitals and clinics, and home care.
Breast Cancer Testing Segment to Lead the Market with the Largest Share
The breast cancer testing segment is emerging as the leading application within the Asia-Pacific women’s health diagnostics market, driven by rising incidence rates and increasing awareness of early detection across the region. Governments and healthcare organizations are expanding national screening initiatives, particularly in populous countries such as China, India, and Japan, to improve early diagnosis and treatment outcomes. Growing adoption of ultrasound, mammography, and molecular diagnostic tests is enhancing diagnostic reach, especially in urban healthcare centers. Technological advancements that improve affordability and accessibility are further supporting wider utilization of breast cancer diagnostics. As awareness and screening coverage continue to expand, this segment is expected to maintain the largest share of the regional market.
Hospitals and Clinics: A Key End-User Segment Driving Market Growth
Hospitals and clinics represent the dominant end-user segment in the Asia-Pacific women’s health diagnostics market, supported by their central role in primary screening, prenatal care, and disease diagnosis. These facilities are increasingly equipped with advanced imaging systems and laboratory diagnostics to manage growing patient volumes. Rising investments in healthcare infrastructure and workforce development are strengthening diagnostic capabilities across both public and private hospitals. Additionally, increasing patient visits for routine health check-ups and maternal care are driving sustained demand for diagnostic services. Together, these factors reinforce the strong contribution of hospitals and clinics to regional market growth.
Regional Outlook
Asia-Pacific women’s health diagnostics market is further divided by countries, including China, Japan, South Korea, India, Australia & New Zealand, ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, and others), and the Rest of Asia-Pacific.
China Dominates the Market with Major Share
China holds a leading position in the Asia-Pacific women’s health diagnostics market, supported by its large female population, expanding healthcare infrastructure, and strong government emphasis on preventive care. National screening initiatives for breast and cervical cancer, along with growing investments in maternal and reproductive health programs, are driving high diagnostic volumes across public and private healthcare facilities. The country’s rapid adoption of advanced diagnostic technologies, including molecular diagnostics, ultrasound imaging, and automated laboratory systems, is improving early detection and clinical efficiency. Domestic diagnostic manufacturers are also strengthening product portfolios to meet rising demand for cost-effective and scalable solutions. As awareness of women-specific health conditions continues to grow and access to diagnostic services expands, China’s dominant market position within the Asia-Pacific region is expected to remain strong.
Market Players Outlook
The major companies operating in the Asia-Pacific women’s health diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., Koninklijke Philips N.V., Siemens Healthineers AG, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In June 2025, Roche Diagnostics expanded its women’s health diagnostics presence across Asia-Pacific with the rollout of localized HPV and cervical cancer molecular testing solutions. The launch focuses on improving early detection capabilities and expanding access to high-throughput screening in emerging markets such as China, India, and Southeast Asia.
- In April 2025, Siemens Healthineers introduced advanced AI-enabled ultrasound and imaging platforms tailored for women’s health applications across Asia-Pacific. The solutions aim to enhance prenatal diagnostics and breast imaging accuracy while improving workflow efficiency in hospitals and diagnostic centers.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the Asia-Pacific women’s health diagnostics Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Asia-Pacific Women’s Health Diagnostics Market Sales Analysis – Application | End-Users ($ Million)
- Women’s Health Diagnostics Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Asia-Pacific Women’s Health Diagnostics Industry Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Asia-Pacific Women’s Health Diagnostics Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Asia-Pacific Women’s Health Diagnostics Market: Impact Analysis
- Market Opportunities
- Opportunities For Asia-Pacific Women’s Health Diagnostics Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Asia-Pacific Women’s Health Diagnostics Market Revenue and Share by Manufacturers
- Women’s Health Diagnostics Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hoffmann-La Roche Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GE HealthCare Technologies Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Koninklijke Philips N.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Abbott Laboratories
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Asia-Pacific Women’s Health Diagnostics Market Sales Analysis by Application ($ Million)
- Breast Cancer Testing
- Cervical Cancer Testing
- Pregnancy & Fertility Testing
- Ovarian Cancer Testing
- Infectious Disease Testing
- Ultrasound Tests
- Sexually Transmitted Disease Testing
- Others
- Asia-Pacific Women’s Health Diagnostics Market Sales Analysis by End-Users ($ Million)
- Diagnostic and Imaging Centers
- Hospitals and Clinics
- Home Care
- Regional Analysis
- Asia-Pacific Women’s Health Diagnostics Market Sales Analysis – Application | End-Users | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And others)
- Rest of Asia-Pacific
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- bioMérieux SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Canon Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardinal Health, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cook Group Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fujifilm Holdings Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fujirebio Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE HealthCare Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hitachi, Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hologic, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PerkinElmer, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Quest Diagnostics Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shimadzu Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sysmex Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- URIT Medical Electronic Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
2. Asia-Pacific Breast Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Asia-Pacific Cervical Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Asia-Pacific Pregnancy & Fertility Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Asia-Pacific bal Ovarian Cancer Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Asia-Pacific Infectious Disease Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Asia-Pacific Ultrasound Tests Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Asia-Pacific Sexually Transmitted Disease Testing Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Asia-Pacific Others Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
11. Asia-Pacific Women’s Health Diagnostics for Diagnostic and Imaging Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Asia-Pacific Women’s Health Diagnostics for Hospitals and Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Asia-Pacific Women’s Health Diagnostics for Home Care Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by Application, 2025–2035 ($ Million)
16. Asia-Pacific Women’s Health Diagnostics Market Research and Analysis by End-Users, 2025–2035 ($ Million)
1. Asia-Pacific Women’s Health Diagnostics Market Share by Application, 2025 Vs 2035 (%)
2. Asia-Pacific Breast Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
3. Asia-Pacific Cervical Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
4. Asia-Pacific Pregnancy & Fertility Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
5. Asia-Pacific Ovarian Cancer Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
6. Asia-Pacific Infectious Disease Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
7. Asia-Pacific Ultrasound Tests Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
8. Asia-Pacific Sexually Transmitted Disease Testing Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
9. Asia-Pacific Others Women’s Health Diagnostics Market Share by Region, 2025 Vs 2035 (%)
10. Asia-Pacific Women’s Health Diagnostics Market Share by End-Users, 2025 Vs 2035 (%)
11. Asia-Pacific Women’s Health Diagnostics for Diagnostic and Imaging Centers Market Share by Region, 2025 Vs 2035 (%)
12. Asia-Pacific Women’s Health Diagnostics for Hospitals and Clinics Market Share by Region, 2025 Vs 2035 (%)
13. Asia-Pacific Women’s Health Diagnostics for Home Care Market Share by Region, 2025 Vs 2035 (%)
14. Asia-Pacific Women’s Health Diagnostics Market Share by Region, 2024 Vs 2035 (%)
15. China Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
16. Japan Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
17. South Korea Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
18. India Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
19. Australia & New Zealand Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
20. ASEAN Countries Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
21. Rest of Asia-Pacific Women’s Health Diagnostics Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
